サマリー

Targeted Biomarker refers to biochemical indicators that can mark changes or possible changes in the structure or function of systems, organs, tissues, cells, and subcellular cells, and has a wide range of uses.
Targeted Biomarker can be used to diagnose diseases, determine stage of disease, or to evaluate the safety and effectiveness of new drugs or treatments in target populations.

Market Analysis and Insights: Global Targeted Biomarker Market
The global Targeted Biomarker market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Targeted Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Targeted Biomarker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Targeted Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Targeted Biomarker market.

Global Targeted Biomarker Scope and Market Size
Targeted Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Targeted Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Safety biomarker
Efficacy biomarker
Validation biomarker

Segment by Application
Diagnostics development
Drug discovery & development
Personalized medicine
Disease risk assessment
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
bioMerieux
IntegraGen
Myriad Genetics
Protagen
Qiagen
PerkinElmer
Merck Millipore
Bio-Rad Laboratories
Enzo Biochem
EKF Diagnostics
Meso Scale Diagnostics, LLC.

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Safety biomarker
1.2.3 Efficacy biomarker
1.2.4 Validation biomarker
1.3 Market by Application
1.3.1 Global Targeted Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostics development
1.3.3 Drug discovery & development
1.3.4 Personalized medicine
1.3.5 Disease risk assessment
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Targeted Biomarker Market Perspective (2016-2027)
2.2 Targeted Biomarker Growth Trends by Regions
2.2.1 Targeted Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Targeted Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Targeted Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Targeted Biomarker Industry Dynamic
2.3.1 Targeted Biomarker Market Trends
2.3.2 Targeted Biomarker Market Drivers
2.3.3 Targeted Biomarker Market Challenges
2.3.4 Targeted Biomarker Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Targeted Biomarker Players by Revenue
3.1.1 Global Top Targeted Biomarker Players by Revenue (2016-2021)
3.1.2 Global Targeted Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Targeted Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Targeted Biomarker Revenue
3.4 Global Targeted Biomarker Market Concentration Ratio
3.4.1 Global Targeted Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Biomarker Revenue in 2020
3.5 Targeted Biomarker Key Players Head office and Area Served
3.6 Key Players Targeted Biomarker Product Solution and Service
3.7 Date of Enter into Targeted Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Biomarker Breakdown Data by Type
4.1 Global Targeted Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Targeted Biomarker Forecasted Market Size by Type (2022-2027)

5 Targeted Biomarker Breakdown Data by Application
5.1 Global Targeted Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Targeted Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Targeted Biomarker Market Size (2016-2027)
6.2 North America Targeted Biomarker Market Size by Type
6.2.1 North America Targeted Biomarker Market Size by Type (2016-2021)
6.2.2 North America Targeted Biomarker Market Size by Type (2022-2027)
6.2.3 North America Targeted Biomarker Market Size by Type (2016-2027)
6.3 North America Targeted Biomarker Market Size by Application
6.3.1 North America Targeted Biomarker Market Size by Application (2016-2021)
6.3.2 North America Targeted Biomarker Market Size by Application (2022-2027)
6.3.3 North America Targeted Biomarker Market Size by Application (2016-2027)
6.4 North America Targeted Biomarker Market Size by Country
6.4.1 North America Targeted Biomarker Market Size by Country (2016-2021)
6.4.2 North America Targeted Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Targeted Biomarker Market Size (2016-2027)
7.2 Europe Targeted Biomarker Market Size by Type
7.2.1 Europe Targeted Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Targeted Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Targeted Biomarker Market Size by Type (2016-2027)
7.3 Europe Targeted Biomarker Market Size by Application
7.3.1 Europe Targeted Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Targeted Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Targeted Biomarker Market Size by Application (2016-2027)
7.4 Europe Targeted Biomarker Market Size by Country
7.4.1 Europe Targeted Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Targeted Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Targeted Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Targeted Biomarker Market Size by Type
8.2.1 Asia-Pacific Targeted Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Targeted Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Targeted Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Targeted Biomarker Market Size by Application
8.3.1 Asia-Pacific Targeted Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Targeted Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Targeted Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Targeted Biomarker Market Size by Region
8.4.1 Asia-Pacific Targeted Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Targeted Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Targeted Biomarker Market Size (2016-2027)
9.2 Latin America Targeted Biomarker Market Size by Type
9.2.1 Latin America Targeted Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Targeted Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Targeted Biomarker Market Size by Type (2016-2027)
9.3 Latin America Targeted Biomarker Market Size by Application
9.3.1 Latin America Targeted Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Targeted Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Targeted Biomarker Market Size by Application (2016-2027)
9.4 Latin America Targeted Biomarker Market Size by Country
9.4.1 Latin America Targeted Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Targeted Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Targeted Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Targeted Biomarker Market Size by Type
10.2.1 Middle East & Africa Targeted Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Targeted Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Targeted Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Targeted Biomarker Market Size by Application
10.3.1 Middle East & Africa Targeted Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Targeted Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Targeted Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Targeted Biomarker Market Size by Country
10.4.1 Middle East & Africa Targeted Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Targeted Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 bioMerieux
11.1.1 bioMerieux Company Details
11.1.2 bioMerieux Business Overview
11.1.3 bioMerieux Targeted Biomarker Introduction
11.1.4 bioMerieux Revenue in Targeted Biomarker Business (2016-2021)
11.1.5 bioMerieux Recent Development
11.2 IntegraGen
11.2.1 IntegraGen Company Details
11.2.2 IntegraGen Business Overview
11.2.3 IntegraGen Targeted Biomarker Introduction
11.2.4 IntegraGen Revenue in Targeted Biomarker Business (2016-2021)
11.2.5 IntegraGen Recent Development
11.3 Myriad Genetics
11.3.1 Myriad Genetics Company Details
11.3.2 Myriad Genetics Business Overview
11.3.3 Myriad Genetics Targeted Biomarker Introduction
11.3.4 Myriad Genetics Revenue in Targeted Biomarker Business (2016-2021)
11.3.5 Myriad Genetics Recent Development
11.4 Protagen
11.4.1 Protagen Company Details
11.4.2 Protagen Business Overview
11.4.3 Protagen Targeted Biomarker Introduction
11.4.4 Protagen Revenue in Targeted Biomarker Business (2016-2021)
11.4.5 Protagen Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Targeted Biomarker Introduction
11.5.4 Qiagen Revenue in Targeted Biomarker Business (2016-2021)
11.5.5 Qiagen Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Details
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Targeted Biomarker Introduction
11.6.4 PerkinElmer Revenue in Targeted Biomarker Business (2016-2021)
11.6.5 PerkinElmer Recent Development
11.7 Merck Millipore
11.7.1 Merck Millipore Company Details
11.7.2 Merck Millipore Business Overview
11.7.3 Merck Millipore Targeted Biomarker Introduction
11.7.4 Merck Millipore Revenue in Targeted Biomarker Business (2016-2021)
11.7.5 Merck Millipore Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Targeted Biomarker Introduction
11.8.4 Bio-Rad Laboratories Revenue in Targeted Biomarker Business (2016-2021)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Enzo Biochem
11.9.1 Enzo Biochem Company Details
11.9.2 Enzo Biochem Business Overview
11.9.3 Enzo Biochem Targeted Biomarker Introduction
11.9.4 Enzo Biochem Revenue in Targeted Biomarker Business (2016-2021)
11.9.5 Enzo Biochem Recent Development
11.10 EKF Diagnostics
11.10.1 EKF Diagnostics Company Details
11.10.2 EKF Diagnostics Business Overview
11.10.3 EKF Diagnostics Targeted Biomarker Introduction
11.10.4 EKF Diagnostics Revenue in Targeted Biomarker Business (2016-2021)
11.10.5 EKF Diagnostics Recent Development
11.11 Meso Scale Diagnostics, LLC.
11.11.1 Meso Scale Diagnostics, LLC. Company Details
11.11.2 Meso Scale Diagnostics, LLC. Business Overview
11.11.3 Meso Scale Diagnostics, LLC. Targeted Biomarker Introduction
11.11.4 Meso Scale Diagnostics, LLC. Revenue in Targeted Biomarker Business (2016-2021)
11.11.5 Meso Scale Diagnostics, LLC. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details